Meta AnalysisID 7153

脱氢表雄酮对体外受精的影响:系统评价和Meta分析

CRD42023428885

To evaluate the effectiveness and safety of dehydroepiandrosterone (DHEA) supplementation in the in vitro fertilization (IVF) outcomes and endometrial receptivity.

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
7153
Evidence Id
15711
Core Evidence Id
15711
Source Meta Analysis Id
7137
Herb2 Meta Analysis Id
HBMA007137
Crd Id
CRD42023428885
Title
Effect of dehydroepiandrosterone for in vitro fertilisation: a systematic review and meta-analysis
Review Question
To evaluate the effectiveness and safety of dehydroepiandrosterone (DHEA) supplementation in the in vitro fertilization (IVF) outcomes and endometrial receptivity.
Study Type Included
The randomised controlled trials (RCTs) and half- RCTs were eligible for inclusion.
Condition Being Studied
Dehydroepiandrosterone (DHEA) is the most abundant circulating steroid hormone in humans, in whom it is produced in the adrenal glands, the gonads, and the brain, where it functions predominantly as a metabolic intermediate in the biosynthesis of the androgen and estrogen sex steroids. However, DHEA also has a variety of potential biological effects in its own right, binding to an array of nuclear and cell surface receptors, and acting as a neurosteroid. In the past decades, several studies aimed to prove the benefit of DHEA supplementation during in vitro fertilization (IVF) cycles, but its role has yet to be determined. Therefore, we aimed to compile data from clinical studies with the use of a rigorous ethodology to offer a better understanding of the impact of DHEA addition in the fertility outcomes and endometrial receptivity in IVF cycles.
Participant
Women undergoing in vitro fertilisation (IVF) or intra-cytoplasmic sperm injection (ICSI), or both.
Animal
Human Disease Modelled
Intervention
The intervention is cotreatment with DHEA in the previous menstrual cycle or during COS.
Comparator Control
The control group will receive conventional COS without DHEA supplementation.
Main Outcome
a) Live birth rate, defined as pregnancy beyond 24 weeks' gestation; b) Clinical pregnancy rate (per cycle) as the presence of a gestational sac on transvaginal ultrasound; c) Ongoing pregnancy rate (per cycle) as a pregnancy beyond 12 weeks' gestation; d) Miscarriage rate (per clinical pregnancy) as fetal loss before the 20th week of gestation; e) Endometrial thickness, pattern and volume.
Outcome Measure
Additional Outcome
a) Total oocytes (per cycle) as the total number of oocytes retrieved at pick-up; b) Mature oocytes (per cycle) as the number of mature oocytes obtained; c) Total embryos (per cycle) as the total number of viable embryos available to transfer; d) Serum estradiol (E2) in HCG day; e) helical arterial blood flow index including resistive index (RI), pulse index (PI), peak systolic velocity/end-diastolic blood velocity (S/D); f) Adverse effects.
Study Method
Meta-analysis, Systematic review
Keyword
Dehydroepiandrosterone; Dietary Supplements; Endometrium; Female; Fertilization in Vitro; Humans
Contact
LING HUANG [email protected]
Organisational Affiliation
BEIJING UNIVERSITY OF CHINESE MEDICINE
Funding Source
National Natural Science Foundation of China
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
China
Review Stage
Review Ongoing
First Submission Date
2023-05-23
Registration Date
2023-06-03
Anticipated Start Date
2023-05-23
Anticipated Completion Date
2023-07-31
Title Cn
脱氢表雄酮对体外受精的影响:系统评价和Meta分析
Title En
Effect of dehydroepiandrosterone for in vitro fertilisation: a systematic review and meta-analysis
Bilingual Status
complete